Fresenius Medical Care AG

NYSE:FMS Stock Report

Market Cap: US$12.5b

Fresenius Medical Care Future Growth

Future criteria checks 2/6

Fresenius Medical Care is forecast to grow earnings and revenue by 19.3% and 3.7% per annum respectively. EPS is expected to grow by 18% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

19.3%

Earnings growth rate

18.0%

EPS growth rate

Healthcare earnings growth20.9%
Revenue growth rate3.7%
Future return on equity7.7%
Analyst coverage

Good

Last updated06 Nov 2024

Recent future growth updates

Recent updates

Fresenius Medical Care: Let's Look At The Upside

Oct 04

Fresenius Medical Care: Significant Upside Remains

Jun 25

Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns

Feb 23

Fresenius Medical Care: Don't Let The Ozempic Kidney Failure Scare You Off

Oct 12

Fresenius Medical Care: Other Stocks Still Better, But Upside Exists

Jun 01

Fresenius Medical Care Q4 2022 Earnings Preview

Feb 21

Fresenius: The Company Is Climbing, And I'm At 'Buy'

Jan 06

Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)

Oct 27

Fresenius Medical gains after report of activist Elliott stake in Fresenius SE

Oct 19

Fresenius cut to Hold at Jefferies citing staffing issues and inflation

Oct 10

Fresenius gets award to provide dialysis services to U.S. military veterans

Aug 30

Fresenius appoints head of pharma unit as new CEO

Aug 19

Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend Aristocrat

Jul 30

Fresenius Medical Care accused of Medicare fraud in dialysis

Jul 13

Fresenius: The Upside Is Getting Bigger

May 02

You Really Want To Know About Fresenius Medical Care

Aug 28

Fresenius Medical drops 12% on disappointing 2021 outlook

Feb 02

Fresenius Medical Care EPS beats by €0.06, misses on revenue

Oct 29

Earnings and Revenue Growth Forecasts

NYSE:FMS - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202620,6301,1021,8782,71316
12/31/202519,8709361,9562,56218
12/31/202419,2586761,7832,57218
9/30/202419,2396591,5382,274N/A
6/30/202419,4155301,3422,049N/A
3/31/202419,4744841,9112,613N/A
12/31/202319,4544991,9182,629N/A
9/30/202319,4634501,7992,509N/A
6/30/202319,6225961,6742,407N/A
3/31/202319,5546021,4012,152N/A
12/31/202219,3986731,3972,167N/A
9/30/202219,0487631,4442,237N/A
6/30/202218,3938061,4442,271N/A
3/31/202217,9578781,5762,441N/A
12/31/202117,6199691,6032,489N/A
9/30/202117,3729181,4772,405N/A
6/30/202117,3449981,4802,459N/A
3/31/202117,5811,1312,8693,857N/A
12/31/202017,8591,1643,1484,233N/A
9/30/202018,0391,3303,2994,420N/A
6/30/202018,0441,3093,3774,542N/A
3/31/202017,8321,2121,8323,075N/A
12/31/201917,4771,2001,4042,567N/A
9/30/201917,1961,2821,3672,494N/A
6/30/201916,8351,2341,2462,379N/A
3/31/201916,7041,9741,0652,182N/A
12/31/201816,5471,9829202,062N/A
9/30/201816,6761,9517661,892N/A
6/30/201816,9541,975N/A1,750N/A
3/31/201817,2111,250N/A1,977N/A
12/31/201717,7841,280N/A2,192N/A
9/30/201717,7711,249N/A2,436N/A
6/30/201717,6471,244N/A2,217N/A
3/31/201717,2011,239N/A1,938N/A
12/31/201616,5701,144N/A1,932N/A
9/30/201616,1011,063N/A1,648N/A
6/30/201615,841998N/A1,782N/A
3/31/201615,402933N/A1,491N/A
12/31/201515,455955N/A1,767N/A
9/30/201515,345939N/A1,791N/A
6/30/201515,246948N/A1,914N/A
3/31/201515,428977N/A2,044N/A
12/31/201413,329864N/A1,538N/A
9/30/201412,413839N/A1,476N/A
6/30/201411,112775N/A1,283N/A
3/31/201410,882791N/A1,329N/A
12/31/201310,816806N/A1,478N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: FMS's forecast earnings growth (19.3% per year) is above the savings rate (2.6%).

Earnings vs Market: FMS's earnings (19.3% per year) are forecast to grow faster than the US market (15.5% per year).

High Growth Earnings: FMS's earnings are forecast to grow, but not significantly.

Revenue vs Market: FMS's revenue (3.7% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: FMS's revenue (3.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: FMS's Return on Equity is forecast to be low in 3 years time (7.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y